U.S. Stock News

OTCPK:AMNF
OTCPK:AMNFFood

Armanino Foods (AMNF) Stock Holds Firm As Margins Stay Rich

Armanino Foods of Distinction stock inched up 2.7% to close at US$11.50, a calm reaction for a company that just put another quarter of solid profit on the table. The market appears to be treating this as business as usual. Yet earnings per share of about US$0.16 and a net profit margin near 25% keep reinforcing one story that matters more than the day’s modest move: this is a packaged food company quietly defending rich profitability while trading on a P/E slightly below its industry and...
NYSE:AS
NYSE:ASLuxury

Amer Sports (AS) Stock Can Revenue Momentum Justify Its Premium Multiple

Amer Sports stock barely flinched after earnings, up about 1% to roughly US$34, even though the quarter landed far from quiet. The company delivered a sharp Q2 revenue jump to US$1.63b and a meaningful lift in net income to US$107.2m. Yet earnings per share eased from Q1 levels, which keeps the focus firmly on how much of that top line is flowing through to the bottom line. Investors came into this print after a softer 30 day share move and a rich P/E multiple. The key question now is whether...
NasdaqGS:BRKR
NasdaqGS:BRKRLife Sciences

Bruker (BRKR) Shares Just Moved, So What Is Going On?

Bruker (BRKR) stock is back in focus after the company expanded its collaboration with Atinary Technologies, pairing Bruker instruments with Atinary’s AI driven Self Driving Lab platforms for automated pharmaceutical and chemical R&D workflows. See our latest analysis for Bruker. The Atinary agreement arrives after a busy few weeks for Bruker, with the stock showing a 30.39% 90 day share price return and a 74.74% total shareholder return over the past year. However, longer term total returns...
NYSE:BROS
NYSE:BROSHospitality

3 Growth Stocks Retail Investors May Be Missing as Insider Conviction Holds

Government bond yields have been edging higher as markets react to inflation data and heavier debt issuance, which leaves many growth stocks under pressure. That can create mispricing, especially in fast growing companies where insiders still own meaningful stakes and have clear conviction. This article walks through three stocks from the Fast Growing Stocks With High Insider Ownership screener that fit this profile and explains what makes each one worth a closer look. The three stocks in...
NYSE:RKT
NYSE:RKTDiversified Financial

Higher Mortgage Rates Put Rocket Stock And Housing Finance Names Back On Watch

Long term Treasury yields are climbing on fiscal worries, mortgage costs are rising, and housing related stocks are suddenly back in the spotlight. This mix can punish some companies yet open interesting windows for others that are tied to U.S. mortgage and housing finance. This article walks through three stocks exposed to this rate story, explaining how the same macro shock can create very different potential outcomes for your watchlist. The three stocks below are a starting sample. The...
NasdaqGS:GERN
NasdaqGS:GERNBiotechs

Geron (GERN) After Earnings And New RYTELO Guidance Has The Valuation Story Changed

Geron earnings and new RYTELO guidance draw investor focus Geron (GERN) has moved into the spotlight after reporting second quarter and first half 2026 results, along with fresh full year guidance for its oncology drug RYTELO, giving investors clearer visibility on expected revenue. See our latest analysis for Geron. Against this backdrop, Geron’s share price has reacted positively, with a 10.42% 1 month share price return and a 26.19% 3 month share price return building on a 20.45% year to...
NasdaqGS:FLEX
NasdaqGS:FLEXElectronic

Flex (FLEX) Dropped, So What Is Driving Attention Now?

Flex (NasdaqGS:FLEX) is back in focus after announcing plans to spin off its Cloud and Power Infrastructure segment, while also highlighting its role in data center and AI hardware at the recent OCP APAC Summit. See our latest analysis for Flex. Despite the recent spin off announcement and OCP APAC Summit spotlight, Flex’s share price has cooled in the short term, with a 1 day share price return of down 6% and a 7 day share price return of down 9.23%. However, the year to date share price...
NasdaqCM:JLHL
NasdaqCM:JLHLConstruction

Julong Holding (NasdaqCM:JLHL) Stock Revenue Growth Clashes With Margin Erosion

The market punished Julong Holding on the day after earnings, with the stock falling 7.3% to ¥7.08, but the headline numbers tell a more nuanced story. The core question for you is whether the profit squeeze that worried traders is as severe as the price move suggests. Julong Holding reported first half 2026 revenue of ¥124.3m and net income of ¥11.7m, which keeps trailing net profit margin at 9.6% compared with 10.8% a year earlier. With the stock still trading on a trailing P/E of 38.9x,...
NasdaqGS:HSAI
NasdaqGS:HSAIAuto Components

Hesai (HSAI) Stock Rallies On Profit Strength As One Off Questions Linger

Hesai Group stock closed up 3.9% at US$17.77 on Wednesday, even though the shares are still down over the past week and past quarter. The market is reacting to one thing above all in this earnings print. Q2 marked a cleanly profitable quarter built on lidar revenue of about RMB 861m and a net margin that now sits in the mid teens over the past year. For short term traders that move looks decisive. For anyone thinking over a multi year horizon, the real story is the profit profile behind that...
NYSE:DHR
NYSE:DHRLife Sciences

Danaher (DHR) Stock Looks Reasonable On Cash Flow Yet Stretched On Earnings

Danaher stock has been roughly flat over the past year, while the valuation picture is mixed. A Discounted Cash Flow (DCF) estimate points to a fair price, but broader checks and market multiples suggest the shares are not especially cheap. Over the past 5 years, Danaher has delivered a total return that declined 23.5%, which frames the current valuation debate against a weak longer term share price record. Progress in areas like CRISPR off target analytics and AI enabled digital pathology...
NYSE:DOW
NYSE:DOWChemicals

Dow’s Dividend And Defense Pivot Might Change The Case For Investing In Dow (DOW)

Dow Inc. recently declared a US$0.35 per share dividend, paid on September 11, 2026 to shareholders of record as of August 31, 2026, and entered agreements with Boeing and RTX to support expanded Aegis missile defense system production under the Department of War’s Acquisition Transformation Strategy. This combination of a maintained cash return to shareholders and entry into missile defense manufacturing highlights Dow’s growing role in defense-related supply chains alongside its...
NasdaqGS:FTAI
NasdaqGS:FTAIAerospace & Defense

Can FTAI Aviation (FTAI) Be Undervalued On Its New $2 Billion Financing Facility?

FTAI Aviation (FTAI) just closed a US$2.0b warehouse financing facility for its 2026 SPV, which is expandable to US$3.0b. For you as an investor, this is a key funding move for its aircraft leasing plans. See our latest analysis for FTAI Aviation. Despite the fresh US$2.0b facility, FTAI Aviation’s share price has been choppy recently, with a 7-day share price return down 6.95% and a 90-day share price return down 14.42%. However, the 1-year total shareholder return of 51.39% and very large...
NYSE:DVN
NYSE:DVNOil and Gas

Is Devon Energy (DVN) Quietly Rewriting Its Midstream Strategy With the Solitude Pipeline Bet?

In August 2026, WhiteWater and its partners, including Devon Energy, reached a positive Final Investment Decision to build the Solitude Pipeline System, two 48-inch natural gas pipelines linking the Permian Basin to Katy, Texas, with an initial capacity of about 2.25 billion cubic feet per day targeted for the second half of 2029, subject to regulatory approvals. This commitment deepens Devon’s integration into Permian midstream infrastructure, reinforcing its access to Gulf Coast LNG and...
NYSE:ALB
NYSE:ALBChemicals

Is Albemarle (ALB) Undervalued On Strong Q2 Earnings And New 2026 Guidance?

Albemarle (ALB) is back in focus after its second quarter 2026 report showed US$1,743.31 million in sales and US$479.96 million in net income, alongside fresh full year guidance on revenue and lithium volumes. See our latest analysis for Albemarle. Following Albemarle’s strong second quarter results and refreshed 2026 guidance, the stock’s recent 13.6% one-month share price return contrasts with a 20.97% decline over three months, while the one-year total shareholder return of 74.22%...
NasdaqGS:FSUN
NasdaqGS:FSUNBanks

3 U.S. Bank Stocks Tied To Cash Management After The Treasury Buyback Shift

Long term Treasury yields just took a step down after the U.S. Treasury moved to ramp up buybacks, and that small shift in borrowing costs is rippling through equity markets. When cash suddenly looks a bit less comfortable, investors often start hunting for better ways to put short term money to work. This article walks through 3 stocks exposed to that policy news and explains how each might benefit or face new tradeoffs. The three stocks below are just a sample from this theme, and the full...
NYSE:WHD
NYSE:WHDEnergy Services

How Higher Oil Prices And Onshore Activity At Cactus (WHD) Has Changed Its Investment Story

In recent weeks, oil prices moving above US$80 per barrel have lifted investor interest in energy-related companies, including Cactus, which supplies engineered pressure control equipment and spoolable pipe for onshore drilling, completion, and production activity. This development underscores how Cactus’ focus on specialized wellhead and pipe technologies closely ties its business fortunes to shifts in commodity-driven oilfield activity and spending patterns. We’ll now explore how stronger...
NasdaqGM:TNDM
NasdaqGM:TNDMMedical Equipment

How Tandem’s Q2 Loss and Pharmacy Pivot Will Impact Tandem Diabetes Care (TNDM) Investors

Tandem Diabetes Care, Inc. reported past second-quarter 2026 results with sales of US$254.56 million and a net loss of US$21.17 million, while reaffirming full-year 2026 sales guidance of about US$1.07 billion to US$1.09 billion. Alongside these results, Tandem’s push into pharmacy-based pump distribution and new insulin delivery technologies suggests a meaningful shift in how it generates and sources its revenue. We’ll now examine how the pharmacy pay-as-you-go shift could reshape Tandem...
NYSE:CRM
NYSE:CRMSoftware

Salesforce (CRM) Is Up 6.6% After U.S. Army Selects Agentforce For Secure AI HR Support

In recent weeks, Salesforce has expanded its enterprise AI footprint, highlighted by the U.S. Army Human Resources Command selecting Agentforce for secure, autonomous HR support within an IL5-authorized environment and by leadership changes including Srini Tallapragada stepping down to a Special Advisor role. Together with Agentforce’s very large ARR growth and upcoming high-profile AI keynotes, these developments underscore Salesforce’s push to embed agentic AI deeply into mission-critical...
NYSE:P
NYSE:PTech

What Everpure (P)'s Second Hyperscaler Design Win Means For Shareholders

In August 2026, Everpure Inc. announced a design win and supply agreement with a second top-five hyperscaler, expanding deployment of its software-powered DirectFlash technology to optimize hyperscale storage architectures for AI and next-generation workloads. This agreement deepens Everpure’s presence in the newly addressable hyperscale market and is expected to become a meaningful revenue contributor from fiscal 2028. We’ll now explore how this second top-five hyperscaler design win may...
NYSE:BDX
NYSE:BDXMedical Equipment

Did Stronger Sales and Quality Shuffle Just Shift Becton Dickinson's (BDX) Investment Narrative?

Becton, Dickinson and Company recently reported third-quarter fiscal 2026 results showing higher sales of US$4,983,000,000 compared with a year earlier, while net income for both the quarter and year-to-date periods was lower than the prior year. Alongside these mixed earnings, BD advanced its tissue regeneration pipeline by fully enrolling the PREVENT trial for Phasix Mesh and reshaped its quality leadership team with the upcoming appointment of Gary Sorsher as chief quality officer and the...
NYSE:ATMU
NYSE:ATMUMachinery

Does Atmus’ Raised 2026 Outlook and Cash Returns Change The Bull Case For Atmus Filtration Technologies (ATMU)?

Atmus Filtration Technologies recently reported second-quarter 2026 results showing sales of US$527.9 million and net income of US$63.9 million, alongside a raised full-year net sales outlook to US$1.975–2.03 billion. The company also increased its quarterly dividend to US$0.06 per share and completed a US$100.98 million buyback, underlining a stronger cash-return profile supported by the integration of its Koch Filter acquisition. Now we will examine how the raised full-year guidance...
NYSE:PRIM
NYSE:PRIMConstruction

What Primoris Services (PRIM)'s Shareholder Lawsuit Over Project Cost Controls Means For Shareholders

A shareholder class action lawsuit was filed in August 2026 against Primoris Services Corporation, alleging deficient cost estimation, cost-to-complete forecasting, and project oversight on significant fixed-price renewable energy projects, which plaintiffs claim led to understated risks, undisclosed cost overruns, and unreliable financial guidance between August 2025 and June 2026. The wave of securities litigation and fiduciary-duty investigations now focuses squarely on Primoris’ core...
NasdaqGM:RAPP
NasdaqGM:RAPPPharmaceuticals

Does Widening Losses And Higher EPS Drag Change The Bull Case For Rapport Therapeutics (RAPP)?

In August 2026, Rapport Therapeutics, Inc. reported second-quarter and half-year 2026 results showing a wider net loss, with Q2 net loss at US$56.62 million and basic loss per share from continuing operations at US$1.19, both higher than the prior year period. The six-month net loss rising to US$76.47 million, alongside a higher loss per share of US$1.61, highlights how spending and earnings trends are weighing more heavily on the company’s financial profile. We will assess how this widening...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

CoStar Group (CSGP) Stock Looks Undervalued Despite Mixed Valuation Signals

CoStar Group stock has had a difficult run over the past year, yet the current market price sits at a discount to an intrinsic value estimate based on a Discounted Cash Flow (DCF) model, while broader valuation checks point to a more mixed picture. Over the past 1 year the share price has declined 61.8%, which means recent investors have faced heavy losses even before considering any valuation upside. Recent housing and multifamily data from CoStar platforms such as Homes.com and...